FUENTE: Private Equity Wire
Private equity fund Abac Solutions and PronoKal Group’s management team have acquired 100 per cent of the company from its founders, in order to support its expansion process in Europe and Latin America.
PronoKal Group makes protein-based dietary treatments for obesity and overweight, with sales in excess of EUR42 million and presence in 15 countries in Europe and Latin America.
The investment by Abac and the management team aims to increase the group’s presence in Europe and Latin America, where obesity is an increasingly widespread disease. PronoKal Group, which will continue to be led by its current management team, will continue research for the development of new treatments and the improvement of the current ones.
Oriol Pinya, founding partner at Abac Capital, says: "We are confident that we can support the management team in accelerating the company's growth through its international expansion, as well as continuing to move towards an increased professionalisation." Dr Joan Fondevila, PronoKal Group’s CEO and one of the co-investors in the deal, says Abac will be crucial to accelerating the company’s growth, as well as investing in new and better treatments.
Read more on: www.privateequitywire.co.uk
Los mayores de 60 años ya no deben resignarse a su sobrepeso: un nuevo tratamiento les permite perder peso sin perder masa muscular [24/04/2017 • medicina21]
Abac Solutions y el equipo directivo de PronoKal Group adquieren el 100% de la compañía líder en tratamientos médicos contra el sobrepeso y la obesidad [03/04/2017 • El Confidencial / El Economista]
Descárgate ya la nueva APP de PronoKal Group®
Contacte con su país
Suscribirse a las noticias de PronoKal Group® - RSS
2013 © PronoKal Group®